• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Nakatake Motomu  中武 大夢

ORCIDConnect your ORCID iD *help
… Alternative Names

NAKATAKE Motomu  中武 大夢

Less
Researcher Number 30903364
Other IDs
Affiliation (Current) 2026: 鳥取大学, 医学部, 助教
Affiliation (based on the past Project Information) *help 2026: 鳥取大学, 医学部, 助教
2022 – 2023: 鳥取大学, 医学部, 特命助教
2021: 鳥取大学, 医学部, プロジェクト研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / 0901:Oncology and related fields
Keywords
Principal Investigator
腫瘍微小環境 / HDAC阻害剤 / 腫瘍溶解性ウイルス療法 / がんウイルス療法 / 癌 / 腫瘍溶解性ウイルス / 遺伝子治療 / 併用療法 / 細胞融合
  • Research Projects

    (3 results)
  • Research Products

    (4 results)
  •  免疫応答のブレーキの解除により強力な抗腫瘍免疫をもたらす腫瘍溶解性ウイルスの開発Principal Investigator

    • Principal Investigator
      中武 大夢
    • Project Period (FY)
      2026 – 2028
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Tottori University
  •  腫瘍溶解性ウイルスの細胞融合による腫瘍微小環境改善効果に立脚した新たな治療戦略Principal Investigator

    • Principal Investigator
      中武 大夢
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Tottori University
  •  Revealing the mechanism of remodeling tumor microenvironment by the cell-cell fusion induction of oncolytic virusPrincipal Investigator

    • Principal Investigator
      NAKATAKE Motomu
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Tottori University

All 2022 2021

All Presentation

  • [Presentation] 腫瘍溶解性ウイルスの治療効果を最適化する細胞融合作用とその強化2022

    • Author(s)
      中武大夢
    • Organizer
      日本遺伝子細胞治療学会 若手研究会セミナー 2022
    • Data Source
      KAKENHI-PROJECT-21K20837
  • [Presentation] Combination of fusogenic oncolytic vaccinia virus and HDAC inhibitor treatment synergistically induces anti-cancer effect through enhancing viral cell-cell fusion.2022

    • Author(s)
      Motomu Nakatake, Hajime Kurosaki and Takafumi Nakamura
    • Organizer
      第28回日本遺伝子細胞治療学会学術集会 (JSGCT2022)
    • Data Source
      KAKENHI-PROJECT-21K20837
  • [Presentation] HDAC inhibitor treatment improves therapeutic efficacy of fusogenic oncolytic vaccinia virus through enhancing the cell-cell fusion2022

    • Author(s)
      Motomu Nakatake, Hajime Kurosaki and Takafumi Nakamura
    • Organizer
      International Oncolytic Virotherapy Conference (IOVC2022)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K20837
  • [Presentation] Fusogenic oncolytic vaccinia virus changes the tumor immune microenvironment by cell fusion and enhances systemic anti-tumor immunity2021

    • Author(s)
      Motomu Nakatake, Nozomi Kuwano, Emi Kaitsurumaru, Hajime Kurosaki and Takafumi Nakamura
    • Organizer
      第27回 日本遺伝子細胞治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-21K20837

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi